Resonant Capital Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-41,199	Closed	-$922K	–	363
2024 Q2	$922K	Sell	41,199 -255	-0.6%	-$5.71K	0.07%	149
2024 Q1	$1.14M	Buy	41,454 +106	+0.3%	+$2.92K	0.1%	133
2023 Q4	$1.26M	Buy	41,348 +10,082	+32%	+$307K	0.12%	126
2023 Q3	$989K	Buy	+31,266	New	+$989K	0.11%	125